helioxanthin has been researched along with nitazoxanide in 2 studies
| Studies (helioxanthin) | Trials (helioxanthin) | Recent Studies (post-2010) (helioxanthin) | Studies (nitazoxanide) | Trials (nitazoxanide) | Recent Studies (post-2010) (nitazoxanide) |
|---|---|---|---|---|---|
| 24 | 0 | 10 | 573 | 85 | 352 |
| Protein | Taxonomy | helioxanthin (IC50) | nitazoxanide (IC50) |
|---|---|---|---|
| Aldo-keto reductase family 1 member B1 | Homo sapiens (human) | 8.22 | |
| Signal transducer and activator of transcription 3 | Homo sapiens (human) | 9.89 | |
| Anoctamin-1 | Homo sapiens (human) | 0.424 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, G; Zhang, F | 1 |
| Liu, G; Pei, Y; Wang, C; Yan, SF | 1 |
2 review(s) available for helioxanthin and nitazoxanide
| Article | Year |
|---|---|
A review of non-nucleoside anti-hepatitis B virus agents.
Topics: Animals; Antiviral Agents; Biological Products; Hepatitis B; Hepatitis B virus; Humans; Small Molecule Libraries | 2014 |
Past, Current, and Future Developments of Therapeutic Agents for Treatment of Chronic Hepatitis B Virus Infection.
Topics: Antiviral Agents; B7-H1 Antigen; Biological Products; Drug Repositioning; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; HSC70 Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Humans; Nucleocapsid; Oligonucleotides, Antisense; Programmed Cell Death 1 Receptor; Ribonuclease H; RNAi Therapeutics; Toll-Like Receptors; Virus Internalization; Virus Replication | 2017 |